FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compound presented by Formula
or Formula 
,
wherein A and B optionally represent CH2, CO; D represent S; the values R1, R2, R4, R4 are specified in cl. 1 of the patent claim, as well as to their pharmacologically acceptable salts or hydrates and methods for preparing them.
EFFECT: compounds are able to inhibit TNF-α recovering cells.
19 cl, 71 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FIVE-MEMBERED HETEROCYCLIC PYRIDINE COMPOUNDS AND PREPARATION METHOD AND USE THEREOF | 2014 |
|
RU2668074C2 |
| HETEROBICYCLIC DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION | 1995 |
|
RU2170737C2 |
| NEW PYRROLOPYRIMIDINE COMPOUND OR ITS SALT, PHARMACEUTICAL COMPOSITION CONTAINING IT, IN PARTICULAR, AGENT FOR PREVENTION AND / OR TREATMENT OF TUMORS AND SO ON, BASED ON INHIBITING INFLUENCE ON NAE | 2015 |
|
RU2658008C2 |
| COMPOUNDS BASED ON 7-SUBSTITUTED PYRROLOTRIAZINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHODS FOR THEIR PREPARATION AND APPLICATION | 2018 |
|
RU2745548C1 |
| ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
| ANTITUMOUR EFFECT ENHANCER CONTAINING PYRROLOPYRIMIDINE COMPOUND | 2016 |
|
RU2710380C1 |
| SUBSTITUTED TRICYCLIC COMPOUNDS AND METHOD OF APPLICATION | 2016 |
|
RU2744766C2 |
| DERIVATIVES OF PYRIDAZINOQUINOLINE | 1994 |
|
RU2168511C2 |
| METHODS FOR GLYCOSGINOPHYLIPIDS OBTAINING AND THEIR APPLICATION | 2012 |
|
RU2636587C2 |
| JAK INHIBITOR COMPOUND AND USE THEREOF | 2020 |
|
RU2820445C2 |
